2-{2-[(difluoromethyl)sulfanyl]-1h-1,3-benzodiazol-1-yl}acetic acid, 97%, 100mg

3,3-dimethyl-2-oxa-8-azaspiro[4.5]decane, 95.0%, 1g

Salzsäure , 5 %, techn., 2.5 l, kunststoffverpackung.

1-(2-Bromo-ethoxy)-1,1,2,2,2-pentafluoro-ethane (stabilized over potassium carbonate), 250mg

(S)-2-Amino-3-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 5g

1-Benzyl-2-methyl-piperazine, 95.0%, 5g

5-Amino-4-cyano-1-(2-hydroxyethyl)-pyrazole, 97.0%, 5g

2,5-dioxopyrrolidin-1-yl 5-(4-(1,2,4,5-tetrazin-3-yl)benzylamino)-5-oxopentanoate, 98%, 10mg

ethyl 11-oxo-2,3,6,7-tetrahydro-1H,5H,11H-pyrano[2,3-f]pyrido[3,2,1-ij]quinoline-10-carboxylate, 95.0%, 1g

tert-Butyl 4-(3-bromopropyl)piperidine-1-carboxylate, 95.0%, 250mg

(R)-N-Boc-2-(2-Hydroxyethyl)morpholine, 95.0%, 100mg

trans-4-Morpholinocyclohexanol hydrochloride, 95.0%, 1g

2,5-Dichlorobenzyl cyanide, 95.0%, 100g